Mark Holdbrook Net Worth & Insider Trades
Mark Holdbrook - V.P., Tarsus Pharmaceuticals, Inc
What is Mark Holdbrook's Net Worth?
The current estimated net worth of Tarsus Pharmaceuticals, Inc's V.P., Mark Holdbrook, is estimated to be about $70.82K . Mark Holdbrook owns about 3,191 units of Tarsus Pharmaceuticals, Inc common stock. In the last 2 years at Tarsus Pharmaceuticals, Inc, Mark Holdbrook has sold an estimated value of $7.5K worth.
What is Mark Holdbrook's Past Insider Trading?
Mark Holdbrook's largest sale order was 386 units , worth over $4.99K on March 21, 2023. In total, Mark Holdbrook has made about 4 transactions over 2 years of their time at Tarsus Pharmaceuticals, Inc. Mark Holdbrook usually trades in March, with the busiest year in 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Mark Holdbrook
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Mark Holdbrook's' Mailing Address?
- Mailing address is 15440 Laguna Canyon Road, Suite 160 Irvine CA 92618 CA
Tarsus Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Bobak Azamian, M.D. Ph.D. | 2020 | $437,000 | $211,484 | $1,847,092 | $14,820 | $2,510,396 |
| Bobak Azamian, M.D. Ph.D. | 2019 | $300,000 | $116,137 | - | - | $416,137 |
| Leo Greenstein | 2020 | $256,023 | $147,437 | $418,703 | $13,280 | $835,443 |
| Seshadri Neervannan, Ph.D.. | 2020 | $199,621 | $85,248 | $1,926,633 | $2,175 | $2,213,677 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1819790/000119312521144962/d150509ddef14a.htm
What are Tarsus Pharmaceuticals, Inc's Past Insider Trades?
Tarsus Pharmaceuticals, Inc's most recent insider trade came on December 1, 2023 by Dianne Whitfield who sold 8,355 units worth $136.27K . In the last 3 years, insiders at Tarsus Pharmaceuticals, Inc have sold an estimated value of $36.98M and bought an estimated value of $16.6M worth of shares. Insider trading is most common in March, with the busiest year in 2023. The most active traders at the company are Bobak Azamian, President/CEO and Board Chair, Aziz Mottiwala, Chief Commercial Officer, and Leonard M Greenstein, Chief Financial Officer .
Tarsus Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||